Direct effects of IL-15 on corticosterone secretion by rat adrenocortical cells

被引:3
作者
Lo, MJ
Lee, SD
机构
[1] Natl Tai Chung Univ, Dept Early Childhood Educ, Taichung 403, Taiwan
[2] Chung Shan Med Univ, Sch Phys Therapy, Taichung, Taiwan
关键词
adrenocorticotropin (ACTH); adenylate cyclase; cAMP; corticosterone; IL-15; zona fasciculata-reticularis cell;
D O I
10.1111/j.1440-1711.2005.01395.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cytokines might regulate the function of the hypothalamic-pituitary-adrenal axis. IL-15 is a potent non-T-cell-derived cytokine with IL-2-like activities. It has been shown that IL-15 can reverse the inhibition of glucocorticoids on PBMC. In vitro experiments were designed to assess the direct effect of IL-15 on corticosterone (CORT) secretion in the adrenal zona fasciculata-reticularis (ZFR) cells of male rats. Administration of IL-15 dose dependently decreased the basal and adrenocorticotropin-stimulated release of CORT and production of cAMP in ZFR cells. The stimulatory effect of forskolin (an adenylate cyclase activator) on CORT secretion and accumulation of cAMP in ZFR cells was attenuated by the administration of IL-15. However, 8-Br-cAMP (a cAMP analogue)-stimulated release of CORT was not affected by IL-15. Exogenous administration of IL-15 (10(-7) mol/L) significantly attenuated the pregnenolone (the substrate of 3 beta-hydroxysteroid dehydrogenase)- or deoxycorticosterone (the substrate of 11 beta-hydroxylase)-induced release of CORT. The results indicate that decrease of CORT secretion by IL-15 is in part because of (i) the decrease of adenylate cyclase activity and cAMP production and (ii) the inhibition of 3 beta-hydroxysteroid dehydrogenase and 11 beta-hydroxylase activities in rat ZFR cells.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 30 条
[1]  
Almendro V, 2005, INT J MOL MED, V15, P963
[2]   Modulation by cytokines of glucocorticoid action [J].
Angeli, A ;
Masera, RG ;
Sartori, ML ;
Fortunati, N ;
Racca, S ;
Dovio, A ;
Staurenghi, A ;
Frairia, R .
NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES, 1999, 876 :210-220
[3]  
[Anonymous], 1980, PRINCIPLES PROCEDURE
[4]  
Besedovsky HO, 2000, Z RHEUMATOL, V59, P26, DOI 10.1007/s003930070014
[5]   Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids [J].
Bianchi, M ;
Meng, C ;
Ivashkiv, LB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9573-9578
[6]   Cytokines and steroidogenesis [J].
Bornstein, SR ;
Rutkowski, H ;
Vrezas, I .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 215 (1-2) :135-141
[7]   Interleukin-15 protects from lethal apoptosis in vivo [J].
BulfonePaus, S ;
Ungureanu, D ;
Pohl, T ;
Lindner, G ;
Paus, R ;
Ruckert, R ;
Krause, H ;
Kunzendorf, U .
NATURE MEDICINE, 1997, 3 (10) :1124-1128
[8]   Interleukin-15 production during liver allograft rejection in humans [J].
Conti, F ;
Frappier, J ;
Dharancy, S ;
Chereau, C ;
Houssin, D ;
Weill, B ;
Calmus, Y .
TRANSPLANTATION, 2003, 76 (01) :210-216
[9]  
Gaillard Rolf-C., 2003, Journal de la Societe de Biologie, V197, P89
[10]   INTERLEUKIN-1-INDUCED CORTICOSTERONE RELEASE OCCURS BY AN ADRENERGIC MECHANISM FROM RAT ADRENAL-GLAND [J].
GWOSDOW, AR ;
OCONNELL, NA ;
SPENCER, JA ;
KUMAR, MSA ;
AGARWAL, RK ;
BODE, HH ;
ABOUSAMRA, AB .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :E461-E466